Loader

Pathways

PathWhiz ID Pathway Meta Data

PW176941

Pw176941 View Pathway
drug action

Cefprozil Action Pathway

Escherichia coli
Cefprozil is a 1-β methyl-carbapenem that is structurally related to beta-lactam antibiotics.5 It was first authorized for use in the US in November 2001 and in Europe in April 2002. Shown to be effective against a wide range of Gram-positive and Gram-negative aerobic and anaerobic bacteria, ertapenem is used to treat various bacterial infections. Cefprozil exhibits a bactericidal mode of action. It works by binding to and inhibiting bacterial penicillin-binding proteins (PBPs).5 In Escherichia coli, it has a strong affinity toward PBPs 1a, 1b, 2, 3, 4 and 5 with preferential binding to PBPs 2 and 3.5 Upon binding to PBPs, ertapenem inhibits bacterial cell wall synthesis by interfering with the lengthening and strengthening of the peptidoglycan portion of the cell wall, thereby inhibiting cell wall synthesis.

PW145238

Pw145238 View Pathway
drug action

Cefprozil Drug Metabolism Action Pathway

Homo sapiens

PW176946

Pw176946 View Pathway
drug action

Cefradine Action Pathway

Escherichia coli
Cefradine is a first-generation cephalosporin antibiotic used in the treatment of bacterial infections of the respiratory and urinary tracts and of the skin and soft tissues. Cefradine exhibits a bactericidal mode of action. It works by binding to and inhibiting bacterial penicillin-binding proteins (PBPs). Upon binding to PBPs, ertapenem inhibits bacterial cell wall synthesis by interfering with the lengthening and strengthening of the peptidoglycan portion of the cell wall, thereby inhibiting cell wall synthesis.

PW145381

Pw145381 View Pathway
drug action

Cefradine Drug Metabolism Action Pathway

Homo sapiens

PW175996

Pw175996 View Pathway
metabolic

Cefradine Predicted Metabolism Pathway new

Homo sapiens
Metabolites of Cefradine are predicted with biotransformer.

PW145719

Pw145719 View Pathway
drug action

Ceftaroline fosamil Drug Metabolism Action Pathway

Homo sapiens

PW176935

Pw176935 View Pathway
drug action

Ceftazidime Action Pathway

Escherichia coli
Ceftazidime is an injected broad-spectrum third-generation cephalosporin beta-lactam antibiotic used to treat or prevent a variety of bacterial infections, including pneumonia, gynecological infections, bone and joint infections, and septicemia. Ceftazidime exhibits a bactericidal mode of action. It works by binding to and inhibiting bacterial penicillin-binding proteins (PBPs). Upon binding to PBPs, ertapenem inhibits bacterial cell wall synthesis by interfering with the lengthening and strengthening of the peptidoglycan portion of the cell wall, thereby inhibiting cell wall synthesis.

PW144563

Pw144563 View Pathway
drug action

Ceftazidime Drug Metabolism Action Pathway

Homo sapiens

PW176948

Pw176948 View Pathway
drug action

Ceftibuten Action Pathway

Escherichia coli
Ceftibuten is a third-generation cephalosporin antibiotic commonly used in the treatment of acute bacterial exacerbations of chronic bronchitis (ABECB), acute bacterial otitis media, pharyngitis, and tonsillitis. Ceftibuten exhibits a bactericidal mode of action. It works by binding to and inhibiting bacterial penicillin-binding proteins (PBPs). Upon binding to PBPs, ertapenem inhibits bacterial cell wall synthesis by interfering with the lengthening and strengthening of the peptidoglycan portion of the cell wall, thereby inhibiting cell wall synthesis.

PW145421

Pw145421 View Pathway
drug action

Ceftibuten Drug Metabolism Action Pathway

Homo sapiens